相关实验视频
Updated: Jun 24, 2025

04:41
Measuring Lactase Enzymatic Activity in the Teaching Lab
Published on: August 6, 2018
113.6K
老年人乳糖吸收不良和乳糖不耐受
Antonella Gallo1, Emanuele Marzetti1,2, Simona Pellegrino2
1Fondazione Policlinico Universitario "A. Gemelli" IRCCS.
概括
老年人乳糖不耐症需要个性化的方法,重点是临床评估而不是测试. 避免过度限制饮食对于维持老年人的营养状况至关重要.
科学领域:
- 老年病的医生 老年病的医生
- 胃肠病学 胃肠病学
- 营养科学 营养科学
背景情况:
- 乳糖吸收不良和乳糖不耐受是常见的疾病,在老年人中具有诊断挑战.
- 老年人面临的营养不良的风险是由于认知障碍,食欲丧失,消化不良,口腔健康不佳.
研究的目的:
- 审查当前的知识,关注点和临床实践对老年人乳糖不良吸收和不耐受性的影响.
- 为解决围绕乳糖不耐症在老年人中最佳诊断和管理策略的辩论.
主要方法:
- 本综述综合了有关老年人乳糖不耐症的当前文献.
- 专注于临床评估和营养影响,而不仅仅是诊断测试.
主要成果:
- 减少老年人的乳制品摄入量可能导致蛋白质和矿物质摄入量不足,影响骨和肌肉健康.
- 在老年人群中,乳糖吸收不良测试可能具有挑战性和潜在的信息不足.
- 临床评估至关重要,以区分乳糖不耐症与其他有类似症状的疾病.
结论:
- 老年人乳糖不耐症的管理需要个性化策略.
- 优先考虑适当的营养状况是必不可少的,反对过度限制饮食措施.
更多相关视频
相关概念视频
Glucose Transporters
22.7K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.7K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Factors Influencing Drug Absorption: Disease States and Pharmacology
495
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
495
Drugs for Treatment of Constipation-Predominant IBS
157
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
157
Other Disorders of Digestive System
783
The gastrointestinal tract is susceptible to various disorders. If the lower esophageal sphincter is damaged, stomach acid can flow back into the esophagus, causing irritation and inflammation of the lining. This condition is called gastroesophageal reflux disease (known as heartburn) and may cause chest pain and difficulty swallowing. In the stomach, prolonged use of nonsteroidal anti-inflammatory drugs like aspirin, chronic alcohol consumption, bacterial infections such as Helicobacter...
783
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
173
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
173

